跳至主要内容
临床试验/NCT02678156
NCT02678156已完成不适用

Assessment of the Performance of LYoplant® ONlay for Duraplasty. A Non-interventional, Multi-centre Post Market Clinical Follow-up (PMCF) Study.

Aesculap AG3 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2016年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Aesculap AG
入组人数
61
试验地点
3
主要终点
Incidence of re-operation because of Cerebrospinal Fluid leakage

研究概览

简要总结

The aim of this Post Market Clinical Follow-up Study is to collect clinical data on the performance of Lyoplant® Onlay. To assess the performance of the product, various safety and efficacy parameters have been selected.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing an elective cranial or spinal surgery, probably with the need of a duraplasty using Lyoplant® Onlay
  • Written informed consent
  • Life expectancy > 6 months
  • Age > 18 years

排除标准

  • Active local or systemic infections
  • Open cranial trauma
  • Open spina bifida
  • Known hypersensitivity to proteins of bovine origin
  • Representation by a legal guardian or under involuntary commitment
  • Pregnancy
  • Participation in another clinical study
  • Known primary immunodeficiency

结局指标

主要结局

Incidence of re-operation because of Cerebrospinal Fluid leakage

时间窗: until discharge (approximately 1 week)

次要结局

  • Incidence of re-operation because of Cerebrospinal Fluid leakage(until follow-up (4 ± 2 months))
  • Incidence of post operative complications(until discharge (approximately 1 week, 4±2 months))
  • Incidence of cerebral reactions edema, soft tissue swelling, Cerebrospinal Fluid leakage(until discharge (approximately 1 week, 4±2 months))
  • Intraoperative handling of the device(Intraoperative)

研究者

发起方
Aesculap AG
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

Assessment of the Performance of LYoplant® ONlay for... | 临床试验